AGI Greenpac Limited

Hemant Surgical Industries Ltd.'s next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, Hemant Surgical Industries Ltd. has 14.53M shares outstanding.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 6.23M in revenue per employee across its workforce of 4,574.50, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Hemant Surgical Industries Ltd. recorded 1.20B in income tax expense. That works out to an effective tax rate of 24.20, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 4.94B, leaving 3.75B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Hemant Surgical Industries Ltd.'s stock has gained approximately 102.69% over the past 52 weeks. The 50-day moving average sits at 486.18, while the 200-day moving average is 364.53.

Over the twelve months ended June 30, 2026, Hemant Surgical Industries Ltd. generated 28.49B in revenue and converted that into 3.75B in net income, yielding earnings per share of 257.94. EBITDA reached 6.15B, while operating income came in at 4.47B.

Over the twelve months ended June 30, 2026, Hemant Surgical Industries Ltd. posted a gross margin of 69.63, reflecting its pricing power and cost economics. The operating margin of 15.68 and net profit margin of 13.16 provide insight into operational efficiency.